ARLINGTON, Va.--(BUSINESS WIRE)--Surescripts, the nation's largest clinical health information network, announced today that President and Chief Executive Officer Harry Totonis will step down effective March 2014. Under Totonis’ leadership, the company has realized pharmacy’s mission to make e-prescribing a reality and established the nation’s leading clinical network to enable nationwide health information exchange. Totonis joined Surescripts shortly after its merger with RxHub in 2008 and successfully completed the acquisition of Kryptiq in 2012.
“Harry is a visionary – responsible for the transformation of Surescripts into the nation’s leading clinical network that is shaping how healthcare connects and communicates by expanding capabilities to enable interoperability between health systems, physicians and pharmacists,” said Steven Miller, MD, Co-Chairman of Surescripts’ Board of Directors. “We are extremely pleased with what Harry has accomplished and believe the company is well positioned for continued success.”
Under Totonis’ leadership the Surescripts network has grown exponentially to enable the transmission of more than 6 billion health data transactions annually. Today, Surescripts connects more than 500,000 prescribers, 94 percent of community pharmacies, the nation’s PBMs, EHR/EMR vendors and many hospitals, to provide the secure electronic transmission of vital health information, including e-prescriptions, immunization records, continuity of care documents and referrals.
“Surescripts, under Harry’s leadership, has realized pharmacy’s e-prescribing vision to enable pharmacy and providers in producing optimal outcomes and reducing healthcare costs. Harry has also built a team and infrastructure to ensure the company’s continued success and growth, as it evolves to meet the changing needs of a dynamic healthcare environment,” said Douglas Hoey, Co-Chairman of Surescripts’ Board of Directors.
"I joined Surescripts with very clear objectives for the business, and I am proud that we have not just achieved them, but exceeded them. The progress we made is a clear indication of the strength and opportunity of our network and an affirmation of the company’s strategy going forward. This is the right time for the transition, and I am confident Surescripts is in a strong position to continue to deliver on this strategy into the future,” said Totonis.
The Surescripts Board of Directors has hired an executive search firm to find a successor and Totonis is working with the Board to execute an effective transition.
Surescripts operates a national clinical network that connects pharmacies, payers, pharmacy benefit managers, physicians, hospitals, integrated delivery networks, health information exchanges and health technology firms to enable the efficient and secure exchange of health information. Guided by the principles of neutrality, transparency, physician and patient choice, open standards, collaboration and privacy, Surescripts provides information for routine, recurring and emergency care. Together with our network participants, Surescripts is committed to saving lives, improving efficiency and reducing the cost of health care for all. For more information, go to www.surescripts.com and follow us at twitter.com/surescripts.